T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Pfizer booster proves effective against Omicron

COSMOS magazine, 09 Dec 2021

Preliminary study reveals a 25-fold increase in effectiveness from a third vaccine shot.

Flow Cytometry and Drug Discovery

The Medical News, 12 Nov 2021

Flow cytometry is an analytical method that allows cells to be quickly analyzed and categorized by lasers as they pass in single…

Un estudio señala que los anticuerpos contra el COVID-19 duran hasta 12 meses en el 70% de los recuperados

infobae, 08 Jul 2021

Los anticuerpos contra el coronavirus SARS-CoV-2 pueden durar hasta 12 meses en más de un 70% de los pacientes que han superado…

¿Cuánto dura la inmunidad COVID-19? Un repaso por lo que sabe la ciencia hasta ahora

infobae, 01 Jul 2021

En un año y medio de pandemia muchas de las preguntas que surgieron junto con la llegada del SARS-CoV-2 al mundo fueron…

Our genes may be the reason some people struggle to fight off COVID infection. Here's why

ABC.net.au, 29 Apr 2021

Right now, white blood cells known as T-cells are cruising through your body looking for any signs of an infection.

AstraZeneca : le Facteur X

FranceSoir, 24 Mar 2021

L’épidémie de Covid-19 nous aura appris qu’il est urgent de revoir le processus qui permet aux laboratoires pharmaceutiques de…

Piccolo vademecum sul vaccino AstraZeneca - Galileo

Galileonet, 20 Mar 2021

di Anna Lisa Bonfranceschi e Sandro Jannaccone Sono giornate bollenti per AstraZeneca e il suo vaccino, sviluppato in…

Pourquoi la résistance aux vaccins est-elle aussi rare ?

L'actualité, 21 Jan 2021

Il existe un risque grave que les infections courantes ne puissent bientt plus tre soignes cause de la rsistance aux…

Pourquoi la résistance aux vaccins est-elle aussi rare ?

L'actualité, 21 Jan 2021

Il existe un risque grave que les infections courantes ne puissent bientt plus tre soignes cause de la rsistance aux…

Pourquoi la résistance aux vaccins est-elle rare, contrairement à la résistance aux antibiotiques ?

The Conversation, 17 Jan 2021

La résistance aux antibiotiques est un problème mondial dans la mesure où il existe un risque grave que les infections…

Why is Resistance Common in Antibiotics, but Rare in Vaccines?

The National Interest, 13 Jan 2021

Antibiotic resistance is a worldwide problem to the extent that there is a grave risk that common infections will soon become…

MIL-OSI Global: Why resistance is common in antibiotics, but rare in vaccines

Foreign Affairs New Zealand, 11 Jan 2021

– By Celia Souque, Postdoctoral Researcher, Microbiology, University of Oxford Antibiotic resistance is a worldwide problem to…

Why resistance is common in antibiotics, but rare in vaccines

The Conversation, 11 Jan 2021

Antibiotic resistance is a worldwide problem to the extent that there is a grave risk that common infections will soon become…

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Irish Examiner, 25 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

Szczepionka Oxford-AstraZeneca stymuluje produkcję przeciwciał i komórek T

MSN, 21 Dec 2020

© Fot. Shutterstock/Lukasz Szwaj Koronawirus Wyniki badań nad eksperymentalną szczepionką Oxfort/AstraZeneca wskazują na duży…

Vaccin : feu vert de l’Agence européenne, des précisions sur celui d’AstraZeneca et Oxford

Pourquoi Docteur , 21 Dec 2020

L'ESSENTIEL L'Agence européenne du médicament préconise de ne vacciner que les personnes de plus de 16 ans.

Oxford vaccine stimulates broad antibody and T cell functions

SelectScience, 21 Dec 2020

Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19…

Oxford vaccine stimulates broad antibody and T cell functions

The FINANCIAL, 19 Dec 2020

The FINANCIAL -- Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of…

Oxford vaccine stimulates broad antibody and T cell functions

MedicalXpress, 18 Dec 2020

Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1…

UK COVID-19 Update: Long COVID Guidance, GPs' 'Spare Jabs'

Medscape, 18 Dec 2020

These are the UK coronavirus stories you need to know about today. Long COVID Long COVID guidance was issued by the National…

Oxford COVID-19 vaccine's 2-dose regimen elicits ‘broad’ immune response

FOX News, 17 Dec 2020

The University of Oxford’s coronavirus vaccine induces the best immune response when administered in two full-doses…

Oxford vaccine stimulates broad antibody and T cell functions

FirstWord Pharma, 17 Dec 2020

Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1…

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

MSN, 17 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

Oxford Vaccine Stimulates Broad Antibody and T-cell Functions

Technology Networks, 17 Dec 2020

Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1…

News story from Gazetta on Thursday 17 December 2020

Gazetta, 17 Dec 2020

News story from Bridgwater Mercury on Thursday 17 December 2020

Bridgwater Mercury, 17 Dec 2020

News story from Braintree

Braintree & Witham Times, 17 Dec 2020

News story from Bracknell News on Thursday 17 December 2020

Bracknell News, 17 Dec 2020

News story from Bournemoth Daily Echo on Thursday 17 December 2020

Bournemoth Daily Echo, 17 Dec 2020

News story from Bridport News on Thursday 17 December 2020

Bridport News, 17 Dec 2020

News story from The Whitehaven News on Thursday 17 December 2020

The Whitehaven News, 17 Dec 2020

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Epping Forest Guardian, 17 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

News story from Hereford Times on Thursday 17 December 2020

Hereford Times, 17 Dec 2020

News story from Bromsgrove Advertiser on Thursday 17 December 2020

Bromsgrove Advertiser, 17 Dec 2020

News story from Telegraph

Telegraph & Argus, 17 Dec 2020

News story from The Northern Echo on Thursday 17 December 2020

The Northern Echo, 17 Dec 2020

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Winsford Guardian, 17 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

News story from Westmorland Gazette on Thursday 17 December 2020

Westmorland Gazette, 17 Dec 2020

News story from The Press (York) on Thursday 17 December 2020

The Press (York), 17 Dec 2020

News story from The National: The Newspaper that Supports an Independent Scotland on Thursday 17 December 2020

The National: The Newspaper that Supports an Independent Scotland, 17 Dec 2020

News story from Wandsworth Times on Thursday 17 December 2020

Wandsworth Times, 17 Dec 2020